Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,095,297
New position
Shares Held
9,129
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#81
of 156 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $36,872,593 across 15 Diagnostics & Research names. BLLN ranks #4 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
48,390 | $24,260,810 | |
| 2 | DHR |
Danaher Corp /De/
|
24,345 | $4,637,235 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,497 | $1,314,520 | |
| 4 | BLLN |
BillionToOne, Inc.
This page
|
9,129 | $1,095,297 | |
| 5 | ILMN |
Illumina, Inc.
|
4,435 | $779,806 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,637 | $770,862 | |
| 7 | NTRA |
Natera, Inc.
|
2,799 | $759,788 | |
| 8 | WAT |
Waters Corp /De/
|
1,613 | $604,939 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,095,297 | 9,129 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||